TEJNAKSH HEALTHCARE
|
|
BOM : 539428     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : NA |
May 26,2023 |
Price(EOD): βΉ 70.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: βΉ 71.45 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
TEJNAKSH HEALTHCARE | -2.3% | -4.7% | -49.3% |
APOLLO HOSPITALS ENTERPRISE | -0% | 4.5% | 22.8% |
MAX HEALTHCARE INSTITUTE | -2.4% | 22.4% | 46.7% |
FORTIS HEALTHCARE | 0.7% | 11.1% | 18.3% |
DR LAL PATHLABS | 0.3% | 4.9% | 2.3% |
NARAYANA HRUDAYALAYA | 1.6% | 11.8% | 35.8% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.8% | 8.5% | 24.9% |
ASTER DM HEALTHCARE | 5% | 8.5% | 59.1% |
RAINBOW CHILDRENS MEDICARE | 4.5% | 20.6% | 106% |
FUNDAMENTAL ANALYSIS OF TEJNAKSH HEALTHCARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF TEJNAKSH HEALTHCARE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
39.73
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 1.79 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] 3.55
P/B Calculated based on Book Value of Rs 20.06 Cr
[Latest Year - Mar2022 - Consolidated Results ] 6.07
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 11.73 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-2% 1% 1% |
SHARE PRICE MOMENTUM OF TEJNAKSH HEALTHCARE
TEJNAKSH HEALTHCARE vs SENSEX
DEBT OF TEJNAKSH HEALTHCARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.36 0.29 0.48 0.38 |
0.35 0.28 0.47 0.37 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF TEJNAKSH HEALTHCARE
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF TEJNAKSH HEALTHCARE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-0.56% -49.79% -73.4% -101.59% |
-9.83% -66.7% -85.6% -100.86% |
QtrlyTrend |
-8 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
TEJNAKSH HEALTHCARE related INDICES
You may also like the below Video Courses
FAQ about TEJNAKSH HEALTHCARE
Is TEJNAKSH HEALTHCARE good for long term investment?
As on May 26,2023, the Fundamentals of TEJNAKSH HEALTHCARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TEJNAKSH HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is TEJNAKSH HEALTHCARE UnderValued or OverValued?
As on May 26,2023, TEJNAKSH HEALTHCARE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of TEJNAKSH HEALTHCARE ?
As on May 26,2023, the Intrinsic Value of TEJNAKSH HEALTHCARE is Rs. 69.66 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 71.44
Fair Value [Median EV / Sales Model] : Rs. 69.54
Fair Value [Median Price / Sales Model] : Rs. 69.66
Estimated Median Fair Value of TEJNAKSH HEALTHCARE : Rs. 69.66
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is TEJNAKSH HEALTHCARE trading at a Premium or Discount?
As on May 26,2023, TEJNAKSH HEALTHCARE is trading at a Premium of 1% based on the estimates of Median Intrinsic Value!